<DOC>
	<DOCNO>NCT01272752</DOCNO>
	<brief_summary>This pilot study determine safety efficacy investigational product ( IHBG-10 ) weight change change body composition subject start take ( less three month ) certain anti-psychotic medication ( Risperdal , Seroquel , and/or Zyprexa ) .</brief_summary>
	<brief_title>Anti-psychotic Medication ( New Use ) Weight Loss Study</brief_title>
	<detailed_description>A total 30 subject enrol study . They randomize one two group . One group ( 20 subject ) take 500 mg investigational product ( IHBG-10 ) 15 minute prior three main meal day ; subject continue take prescribed anti-psychotic medication . The group ( 10 subject ) take placebo 15 minute prior three main meal day ; subject continue take prescribed anti-psychotic medication . Subjects take investigational product placebo 12 week . Participation study involve 4 study visit .</detailed_description>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Men woman , age 18 old Agree keep diet , exercise current health habit stable participation study Have take Risperdal ( Risperidone ) , Seroquel ( Quetiapine ) , Zyprexa ( Olanzapine ) less 3 month Current active acute psychotic episode Women pregnant , breastfeed plan become pregnant Prior bariatric surgery Use prescription overthecounter appetite suppressant , herbal product medication weight loss within past month Obesity result clinicallydiagnosed endocrine problem</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>obesity</keyword>
	<keyword>weight loss</keyword>
	<keyword>weight management</keyword>
	<keyword>anti-psychotic medication</keyword>
	<keyword>nutriceutical</keyword>
</DOC>